Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.43T
1-Year Return 25.4%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Quarter Return
+3.3%
1 Year Return
+25.4%
3 Year Return
+109.59%
5 Year Return
+197.61%
10 Year Return
+489.39%
AUM
$254B
AUM Growth
+$10.5B
Cap. Flow
+$3.9B
Cap. Flow %
1.53%
Top 10 Hldgs %
15.87%
Holding
4,231
New
134
Increased
2,757
Reduced
887
Closed
133

Sector Composition

1 Financials 15.9%
2 Technology 15.81%
3 Healthcare 13.92%
4 Industrials 10.47%
5 Consumer Discretionary 9.55%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SMED
3551
DELISTED
Sharps Compliance Corp
SMED
$242K ﹤0.01%
57,439
-2,602
-4% -$11K
FEIM icon
3552
Frequency Electronics
FEIM
$326M
$241K ﹤0.01%
25,327
-1,597
-6% -$15.2K
ENPH icon
3553
Enphase Energy
ENPH
$5B
$240K ﹤0.01%
277,732
-4,104
-1% -$3.55K
LPTH icon
3554
Lightpath Technologies
LPTH
$247M
$240K ﹤0.01%
88,989
+21,634
+32% +$58.3K
NAII icon
3555
Natural Alternatives International
NAII
$23.5M
$239K ﹤0.01%
23,978
+1,503
+7% +$15K
ADVM icon
3556
Adverum Biotechnologies
ADVM
$67.8M
$238K ﹤0.01%
9,525
-4,001
-30% -$100K
GCBC icon
3557
Greene County Bancorp
GCBC
$399M
$238K ﹤0.01%
+17,528
New +$238K
NNVC icon
3558
NanoViricides
NNVC
$22.2M
$237K ﹤0.01%
8,799
BCOM
3559
DELISTED
B Communications Ltd
BCOM
$237K ﹤0.01%
13,809
+3,764
+37% +$64.6K
NVLN
3560
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$237K ﹤0.01%
+25,722
New +$237K
ANCB
3561
DELISTED
Anchor Bancorp
ANCB
$237K ﹤0.01%
9,419
-445
-5% -$11.2K
AMPY icon
3562
Amplify Energy
AMPY
$160M
$235K ﹤0.01%
+18,563
New +$235K
BBAR icon
3563
BBVA Argentina
BBAR
$2.48B
$235K ﹤0.01%
12,438
-337
-3% -$6.37K
EYPT icon
3564
EyePoint Pharmaceuticals
EYPT
$828M
$235K ﹤0.01%
13,748
-557
-4% -$9.52K
FCSC
3565
DELISTED
Fibrocell Science Inc.
FCSC
$235K ﹤0.01%
11,742
-343
-3% -$6.87K
INSE icon
3566
Inspired Entertainment
INSE
$252M
$234K ﹤0.01%
+18,031
New +$234K
VBIV
3567
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$234K ﹤0.01%
1,799
+1,050
+140% +$137K
ATNM icon
3568
Actinium Pharmaceuticals
ATNM
$51.5M
$233K ﹤0.01%
6,375
+1,332
+26% +$48.7K
EPD icon
3569
Enterprise Products Partners
EPD
$69B
$233K ﹤0.01%
8,610
WF icon
3570
Woori Financial
WF
$13B
$233K ﹤0.01%
+4,787
New +$233K
PAR icon
3571
PAR Technology
PAR
$2.01B
$232K ﹤0.01%
27,309
ATAXZ
3572
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$232K ﹤0.01%
39,141
-1,437
-4% -$8.52K
SVA
3573
DELISTED
Sinovac Biotech, Ltd
SVA
$232K ﹤0.01%
34,487
-4,989
-13% -$33.6K
SCYX icon
3574
SCYNEXIS
SCYX
$36.8M
$230K ﹤0.01%
12,872
-323
-2% -$5.77K
SLRX icon
3575
Salarius Pharmaceuticals
SLRX
$2.44M
$230K ﹤0.01%
1